COMPLEMENT FACTOR B INHIBITORS AND THEIR USES

ID202605952APending Publication Date: 2026-07-17NOVARTIS AG

Patent Information

Authority / Receiving Office
ID · ID
Patent Type
Applications
Current Assignee / Owner
NOVARTIS AG
Filing Date
2024-09-26
Publication Date
2026-07-17
Patent Text Reader

Abstract

Available herein are compounds of Formula (I) and pharmaceutical compositions thereof useful for treating diseases or disorders mediated by complement factor B.
Need to check novelty before this filing date? Find Prior Art